comparano
Hyperlipidemia Management for Primary Care

Hyperlipidemia Management for Primary Care

Springer New York·Grāmatas·EAN 9780387766065

Labākā cena no 1 piedāvājuma

85,59 €

Salīdzināt 1 cenu

VeikalsCenaAction

Springer Nature

link.springer.com

Labākā cena

Ir noliktavā

85,59 €Doties → Uz veikalu →

Cenu brīdinājums

Mēs nosūtīsim e-pastu, kad cena nokritīs zem jūsu norādītā līmeņa.

Nospiežot “Paziņot man”, jūs piekrītat saņemt vienu apstiprinājuma e-pastu un vienu paziņojumu par šī produkta cenu. Jebkurā brīdī varat atteikties.

Cenu vēsture — zemākā cena

85,59 €

Zemākā dienas cena visos veikalos · vidējā cena šajā periodā: 85,59 €

One of the possible bene?ts of 30 years of medical practice is the ability to develop some sense of perspectivewith regardto majortransitionsin medicine. Manyphy- cians who graduated from medical school in the mid- to late 1970s may recall fe- ing less than comfortable about counseling patients regarding lifestyle modi?cation and heart disease risk. A total cholesterol of 250 mg% at that time was considered within normal limits. The best information on the causation of heart disease came from epidemiologic data showing associations between increased consumption of dairy products and fat in the industrialized countries of northern Europe and Am- ica, and a corresponding increase in morbidity and mortality from heart disease as compared to other countries that were less well developed or as compared to Mediterranean countries, where there was a different type of diet lower in saturated fats and cholesterol. Treatment options in those days were based more on anecdotal information and observation than on evidence. The idea that coronary artery disease was an in?- matory problem in which the main culprit was oxidized LDL and the idea that heart disease risk could be managed had not yet made the transition to clinical pr- tice. This attitude all changed as information from the largest and longest running prospective epidemiologic study on heart disease—the Framingham Study—began publishing data on causality and risk factors.

Comparano salīdzina Hyperlipidemia Management for Primary Care cenas 1 interneta veikalā. Labākā cena šodien ir 85,59 €. Pēdējo 90 dienu laikā zemākā dienas cena vidēji bija 85,59 €. Cenas tiek atjauninātas vairākas reizes dienā; galīgā cena tiek apstiprināta veikalā.

Vairāk no Springer New York